Effects of Caffeine, L-Theanine, and Diaphragmatic Breathing on Esports Players' Performance (CLD Esports St)

September 27, 2024 updated by: Sedat Arslan, Hacettepe University

Can L-Theanine Supplementation or Diaphragmatic Breathing Exercises in Addition to Caffeine Supplementation Be Used as Ergogenic Aids to Influence Game Performance in Esports Players?

The purpose of this study is to investigate whether caffeine, L-theanine (a natural amino acid found in tea), and diaphragmatic breathing exercises can help improve the game performance of esports players. Esports players often need fast reaction times, high accuracy, and mental focus during competitive gaming. This study will look at how caffeine and L-theanine supplements, either separately or together, and breathing exercises impact key performance factors like reaction time and accuracy during gameplay. The goal is to determine if these strategies can help esports players perform better by reducing stress, improving concentration, and speeding up reaction times. The findings could help inform safe, effective methods to enhance cognitive and physical performance in gaming.

Study Overview

Detailed Description

This study explores the effects of caffeine, L-theanine supplementation, and diaphragmatic breathing exercises on esports players' game performance, focusing on reaction time and accuracy. Caffeine is widely recognized for its stimulating effects, improving attention and reducing fatigue, while L-theanine, found in tea, is known to reduce stress and balance the effects of caffeine. Diaphragmatic breathing exercises are designed to lower stress levels, improve focus, and enhance cognitive function.

The study utilizes a randomized, single-blind crossover design, where participants-esports players aged 18-30-will undergo three different interventions: caffeine only, caffeine combined with L-theanine, and caffeine combined with diaphragmatic breathing exercises. Performance outcomes, including reaction time and accuracy, will be assessed using game-based software and tests. Participants will have their performance measured before and after each intervention, allowing for comparison between the different strategies.

This study aims to determine whether these supplements and exercises, alone or in combination, can serve as effective ergogenic aids, helping esports players optimize their performance by improving cognitive and motor skills, while also reducing stress. These findings could have broader applications for enhancing mental performance in competitive environments.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Balıkesir, Turkey
        • Bandirma Onyedi Eylül University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male esports players aged 18-30.
  • Actively involved in esports for at least 6 hours per week for a minimum of 6 months.
  • Low caffeine consumption (less than 80 mg per day).
  • Low L-theanine consumption (less than 100 mg per day).
  • Non-smokers or those who do not use tobacco products.
  • No recent history of upper extremity surgery.
  • No known allergies to caffeine or L-theanine.
  • No neurological, visual, or auditory disorders.
  • No use of drugs or performance-enhancing supplements within the past month.
  • No alcohol consumption within the past week.

Exclusion Criteria:

  • Use of stimulant medications.
  • History of upper extremity surgery.
  • Diagnosed neurological, visual, or auditory disorders.
  • Allergy to caffeine or L-theanine.
  • Use of drugs or performance-enhancing supplements within the past month.
  • Regular tobacco use.
  • Consumption of alcohol in the past week.
  • Inconsistent sleep patterns or difficulty following standardized sleep and hydration guidelines.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Caffeine Only Arm
Participants receive a caffeine supplement only.
Participants in this group will receive a caffeine supplement (3 mg/kg body weight) taken orally 45 minutes before performance testing. No additional interventions will be administered.
Experimental: Caffeine + L-Theanine Arm
Participants receive a combination of caffeine and L-theanine supplements.
Participants in this group will receive a caffeine supplement (3 mg/kg body weight) along with L-theanine in a 1:2 ratio taken orally 45 minutes before performance testing.
Experimental: Caffeine + Diaphragmatic Breathing Exercises Arm
Participants receive a caffeine supplement and perform diaphragmatic breathing exercises.
Participants in this group will receive a caffeine supplement (3 mg/kg body weight) 45 minutes before performance testing, followed by a 10-minute session of diaphragmatic breathing exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reaction Time
Time Frame: Reaction time will be assessed immediately before each intervention and at two time points after each intervention (at 45 minutes and 2 hours post-intervention) on each of the three study days.
The time it takes for participants to respond to visual and auditory stimuli during gaming, measured in milliseconds using Aim Lab and other standardized reaction time tests.
Reaction time will be assessed immediately before each intervention and at two time points after each intervention (at 45 minutes and 2 hours post-intervention) on each of the three study days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Actual)

September 24, 2024

Study Completion (Actual)

September 26, 2024

Study Registration Dates

First Submitted

September 26, 2024

First Submitted That Met QC Criteria

September 27, 2024

First Posted (Actual)

October 1, 2024

Study Record Updates

Last Update Posted (Actual)

October 1, 2024

Last Update Submitted That Met QC Criteria

September 27, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No, there is no plan to share IPD with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caffeine

Clinical Trials on Intervention 1: Dietary Supplement - Caffeine Supplement

Subscribe